Li Y - Search Results

1

Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3.

Fu S, Li Y, Huang J, Liu T, Hong Z, Chen A, Bast RC, Kavanagh JJ, Gershenson DM, Sood AK, Hu W. Fu S, et al. Among authors: li y. Cancer Biol Ther. 2012 Sep;13(11):1034-41. doi: 10.4161/cbt.21045. Epub 2012 Aug 16. Cancer Biol Ther. 2012. PMID: 22895067 Free PMC article.

2

Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis.

Li Y, Hu W, Shen DY, Kavanagh JJ, Fu S. Li Y, et al. Am J Obstet Gynecol. 2009 Feb;200(2):177.e1-9. doi: 10.1016/j.ajog.2008.08.030. Epub 2008 Dec 25. Am J Obstet Gynecol. 2009. PMID: 19110234

3

Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells.

Li Y, Liu T, Ivan C, Huang J, Shen DY, Kavanagh JJ, Bast RC Jr, Fu S, Hu W, Sood AK. Li Y, et al. Front Oncol. 2013 Mar 20;3:58. doi: 10.3389/fonc.2013.00058. eCollection 2013. Front Oncol. 2013. PMID: 23519775 Free PMC article.

4

Nuclear cyclin B1 is overexpressed in low-malignant-potential ovarian tumors but not in epithelial ovarian cancer.

Zheng H, Hu W, Deavers MT, Shen DY, Fu S, Li YF, Kavanagh JJ. Zheng H, et al. Am J Obstet Gynecol. 2009 Oct;201(4):367.e1-6. doi: 10.1016/j.ajog.2009.05.021. Epub 2009 Jul 15. Am J Obstet Gynecol. 2009. PMID: 19608149

5

Pegylated liposomal doxorubicin treatment in recurrent gynecologic cancer patients with renal dysfunction.

Li Y, Finkel KW, Hu W, Fu S, Liu J, Coleman R, Kavanagh JJ. Li Y, et al. Gynecol Oncol. 2007 Aug;106(2):375-80. doi: 10.1016/j.ygyno.2007.04.011. Epub 2007 May 18. Gynecol Oncol. 2007. PMID: 17512575

6

Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells.

Li Y, Liu T, Ivan C, Huang J, Shen DY, Kavanagh JJ, Bast RC Jr, Fu S, Hu W, Sood AK. Li Y, et al. Front Oncol. 2018 Feb 9;8:9. doi: 10.3389/fonc.2018.00009. eCollection 2018. Front Oncol. 2018. PMID: 29456965 Free PMC article.

7

Poor survival outcome with moderate and severe hypercalcemia in gynecologic malignancy patients.

Jaishuen A, Jimenez C, Sirisabya N, Li Y, Zheng H, Hu W, Urbauer DL, Kavanagh JJ. Jaishuen A, et al. Among authors: li y. Int J Gynecol Cancer. 2009 Feb;19(2):178-85. doi: 10.1111/IGC.0b013e31819c0fd0. Int J Gynecol Cancer. 2009. PMID: 19395991

8

Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.

Sun F, Ding W, He JH, Wang XJ, Ma ZB, Li YF. Sun F, et al. BMC Cancer. 2015 Oct 20;15:746. doi: 10.1186/s12885-015-1723-x. BMC Cancer. 2015. PMID: 26487491 Free PMC article.

9

The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.

Wang XJ, Xiong Y, Ma ZB, Xia JC, Li YF. Wang XJ, et al. Among authors: li yf. Chin J Cancer. 2016 Jun 16;35(1):54. doi: 10.1186/s40880-016-0114-2. Chin J Cancer. 2016. PMID: 27311570 Free PMC article.

10

Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.

Ma Z, Wang X, He J, Xia J, Li Y. Ma Z, et al. Among authors: li y. PLoS One. 2017 Mar 29;12(3):e0174037. doi: 10.1371/journal.pone.0174037. eCollection 2017. PLoS One. 2017. PMID: 28355289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235,681 results

Search Page

Filters